Cargando…
Seneca Valley virus replicons are packaged in trans and have the capacity to overcome the limitations of viral transgene expression
Oncolytic viruses (OVs) promote the anti-tumor immune response as their replication, and the subsequent lysis of tumor cells, triggers the activation of immune-sensing pathways. Arming OVs by expressing transgenes with the potential to promote immune cell recruitment and activation is an attractive...
Autores principales: | Bryant, Jeffrey D., Lee, Jennifer S., De Almeida, Ana, Jacques, Judy, Chang, Ching-Hung, Fassler, William, Quéva, Christophe, Lerner, Lorena, Kennedy, Edward M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018389/ https://www.ncbi.nlm.nih.gov/pubmed/36938543 http://dx.doi.org/10.1016/j.omto.2023.02.005 |
Ejemplares similares
-
Intercellular transmission of Seneca Valley virus mediated by exosomes
por: Xu, Guowei, et al.
Publicado: (2020) -
Oncolytic Seneca Valley Virus: past perspectives and future directions
por: Burke, Michael J
Publicado: (2016) -
Correction to: Intercellular transmission of Seneca Valley virus mediated by exosomes
por: Xu, Guowei, et al.
Publicado: (2020) -
Review of Seneca Valley Virus: A Call for Increased Surveillance and Research
por: Zhang, Xiangle, et al.
Publicado: (2018) -
In vitro and in vivo antiviral activity of monolaurin against Seneca Valley virus
por: Su, Bo, et al.
Publicado: (2023)